Previous Article | Next Article 
Infection and Immunity, May 2000, p. 3019-3022, Vol. 68, No. 5
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Immunoglobulin G3 Antibodies Specific for the
19-Kilodalton Carboxyl-Terminal Fragment of Plasmodium
yoelii Merozoite Surface Protein 1 Transfer Protection to
Mice Deficient in Fc-
RI Receptors
Peter
Vukovic,1
P. Mark
Hogarth,2
Nadine
Barnes,2
David C.
Kaslow,3,
and
Michael
F.
Good1,*
The Cooperative Research Centre for Vaccine
Technology, The Queensland Institute of Medical Research and the
Australian Centre for International and Tropical Health and Nutrition,
The University of Queensland, Brisbane 4029,1
and The Austin Research Institute, Heidelberg
3084,2 Australia, and The Laboratory of
Parasitic Diseases, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Bethesda, Maryland
208923
Received 25 October 1999/Returned for modification 6 December
1999/Accepted 21 February 2000
Merozoite surface protein 1 (MSP-119) is a leading
malaria vaccine candidate. Specific antibodies contribute to immunity; binding to macrophages is believed to represent the main action of
malaria antibodies. We show that an MSP-119-specific
immunoglobulin G3 (IgG3) monoclonal antibody can passively transfer
protection to mice deficient in the
chain of Fc-
RI whose
macrophages cannot bind IgG3.
*
Corresponding author. Mailing address: The Queensland
Institute of Medical Research, P.O. Royal Brisbane Hospital, QLD 4029, Australia. Phone: 61 7 33620404. Fax: 61 7 33620104. E-mail:
michaelG{at}qimr.edu.au.

Present address: Virus and Cell Biology, Merck Research
Laboratories, West Point, PA
19486.
Infection and Immunity, May 2000, p. 3019-3022, Vol. 68, No. 5
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Petritus, P. M., Burns, J. M. Jr.
(2008). Suppression of Lethal Plasmodium yoelii Malaria following Protective Immunization Requires Antibody-, IL-4-, and IFN-{gamma}-Dependent Responses Induced by Vaccination and/or Challenge Infection. J. Immunol.
180: 444-453
[Abstract]
[Full Text]
-
Scorza, T., Grubb, K., Smooker, P., Rainczuk, A., Proll, D., Spithill, T. W.
(2005). Induction of Strain-Transcending Immunity against Plasmodium chabaudi adami Malaria with a Multiepitope DNA Vaccine. Infect. Immun.
73: 2974-2985
[Abstract]
[Full Text]
-
Burns, J. M. Jr., Flaherty, P. R., Nanavati, P., Weidanz, W. P.
(2004). Protection against Plasmodium chabaudi Malaria Induced by Immunization with Apical Membrane Antigen 1 and Merozoite Surface Protein 1 in the Absence of Gamma Interferon or Interleukin-4. Infect. Immun.
72: 5605-5612
[Abstract]
[Full Text]
-
Okech, B. A., Corran, P. H., Todd, J., Joynson-Hicks, A., Uthaipibull, C., Egwang, T. G., Holder, A. A., Riley, E. M.
(2004). Fine Specificity of Serum Antibodies to Plasmodium falciparum Merozoite Surface Protein, PfMSP-119, Predicts Protection from Malaria Infection and High-Density Parasitemia. Infect. Immun.
72: 1557-1567
[Abstract]
[Full Text]
-
Su, Z., Stevenson, M. M.
(2002). IL-12 Is Required for Antibody-Mediated Protective Immunity Against Blood-Stage Plasmodiumchabaudi AS Malaria Infection in Mice. J. Immunol.
168: 1348-1355
[Abstract]
[Full Text]
-
Taylor, P. R., Seixas, E., Walport, M. J., Langhorne, J., Botto, M.
(2001). Complement Contributes to Protective Immunity against Reinfection by Plasmodium chabaudi chabaudi Parasites. Infect. Immun.
69: 3853-3859
[Abstract]
[Full Text]
-
Quin, S. J., Langhorne, J.
(2001). Different Regions of the Malaria Merozoite Surface Protein 1 of Plasmodium chabaudi Elicit Distinct T-Cell and Antibody Isotype Responses. Infect. Immun.
69: 2245-2251
[Abstract]
[Full Text]